期刊文献+

母细胞性浆细胞样树突细胞肿瘤4例临床病理分析 被引量:9

Blastic plasmacytoid dendritic cell neoplasm:a clinicopathologic study of 4 cases
下载PDF
导出
摘要 目的探讨母细胞性浆细胞样树突细胞肿瘤(BPDCN)的临床病理学特征及诊断与鉴别诊断。方法对4例BPDCN的临床病理学特征、免疫表型以及治疗和预后情况进行分析,并复习相关文献。结果 4例患者均为男性,发病年龄20~70岁;2例表现为淋巴结肿大,2例示多发性皮肤斑块或结节。活检组织形态学显示,淋巴结及真皮和皮下由弥漫浸润的小~中等大小幼稚肿瘤细胞浸润,细胞质稀少,核形不规则,染色质细腻,核仁不明显。免疫组化示肿瘤细胞CD4、CD56、CD123、TCL-1和S-100(+)。结论 BPDCN是一种罕见的高度恶性的淋巴造血系统肿瘤,多数病例发生于老年患者,常见皮肤累及;少量病例也可发生于年轻患者或无皮肤受累者。即使给予高强度化疗和同种异体骨髓移植,预后仍很差。 Objective To investigate the features, pathological diagnosis and differential diagnosis of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Methods The clinical and histological findings, immunophenotype, treatment and prognosis in 4 cases of BPDCNs were evaluated with review of the relevant literatures. Results All 4 patients were male, and 2 patients presented as lymphoadenopathy, 2 patients presented as multiple cutaneous lesions, with age from 20 to 70 years. Microscopically, the tumors were composed of diffuse blasts with small to medium size, scant cytoplasm, highly irregular nuclear contours, dispersed nuclear chromatin and faint indistinct nucleolus in lymph nodes ( cases 1 and 2 ) or dermis and subcutaneous tissue (cases 3 and 4)~ Immunophenotypically, the tumor cells were positive for CD4, CD56, CD123, TCL-1 and $100. Conclusions BPDCN is a rare high grade hematopoietic neoplasm with very poor survival even though treated with multiagents chemotherapy and allogeneic bone marrow transplantation. Skin involvement is very common, but young patients with BPDCNs and tumors only with extracutaneous presentations can be seen in rare cases.
出处 《诊断病理学杂志》 CSCD 北大核心 2013年第3期131-136,共6页 Chinese Journal of Diagnostic Pathology
基金 十二五南京市卫生青年人才培养工程项目
关键词 淋巴造血系统肿瘤 母细胞性浆细胞样树突细胞肿瘤 诊断 鉴别诊断 : Lymphoid and hematopoietic neoplasm Blastic plasmacytoid dendritic cell neoplasm Diagnosis Differential diagnosis
  • 相关文献

参考文献28

  • 1Adachi M, Maeda K, Takekawa M, et al. High expression of CD56 (N-CAM) in a patient with cutaneous CIM-positive lymphoma[ J]. Am J Hematol, 1994, 47(4) : 278 -282.
  • 2Swerdlow SH, Campo E, Harris NL. WHO Classification of tumours of haematopoietie and lymphoid tissues [ M ]. 4th ed. Lyon: IARC Press, 2008. 145-147.
  • 3王焱,周晓军,石群立,周航波,马恒辉.母细胞性浆细胞样树突细胞肿瘤临床病理观察[J].诊断病理学杂志,2010,17(5):346-348. 被引量:6
  • 4Jegalian AG, Buxbaum NP, Facchetti F, et al. Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications [ J ]. Haematologica, 2010, 95 ( 11 ) :1873 - 1879.
  • 5Yang CS, Wang J, Chang TK. Congenital blastic plasmacytoid dendritic cell neoplasm [ J ]. Pediatr Blood Cancer, 2012, 58 (1) :109 -110.
  • 6Tsagarakis NJ, Kentrou NA, Papadimitriou KA, et al. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group [ J ]. Leuk Res, 2010, 34(4) :438 -446.
  • 7Rauh M J, Rahman F, Good D, et al. Blastic plasmaeytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: case series and literature review [ J ]. Leuk Res, 2012, 36(1) :81 -86. Su.
  • 8zuki R, Nakamura S, Suzumiya J, et al. Blastic natural killer cell lymphoma/leukemia ( CD56-positive blastic tumor ) : prognostication and categorization according to anatomic sites of involvement[ J]. Cancer, 2005, 104(5) : 1022 - 1031.
  • 9Feuillard J, Jacob MC, Valensi F, et al. Clinical and biologic features of CIM( + )CD56( + ) malignancies[J]. Blood, 2002, 99 (5) : 1556 - 1563.
  • 10Herling M, Jones D. CD4 +/CD56 + hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells [J]. Am J Clin Pathol, 2007, 127(5) : 687 -700.

二级参考文献13

  • 1王焱,石群立,周晓军,马捷,孟奎,马恒辉,周航波.成人淋巴母细胞性淋巴瘤临床病理分析[J].医学研究生学报,2006,19(4):347-349. 被引量:7
  • 2Jaffe ES,Harris NL,Stein H,et al.World Health Organization classification of tumours.Pathologic and genetic of tumours of haematopoietic and lymphoid tissues[M].Lyon:IARC Press,2001.214-215.
  • 3Chaperot L,Perrot I,Jacob MC,et al.Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts[J].Eur J Immunol,2004,34(2):418-426.
  • 4Charperot L,Bendriss N,Manches O,et al.Identification of a leukemic counterpart of the plasmacytoid dendritic cells[J].Blood,2001,97(10):3210-3217.
  • 5Swerdlow SH,Campo E,Harris NL,et al.WHO classification of tumours of heamatopioetics and lymphoid tissues[M].4th ed.Lyon:IARC Press,2008.145-147.
  • 6Adachi M,Maeda K,Takekawa M,et al.High expression of CD56(N182CAM) in a patient with cutaneous CD4-positive lymphoma[J].Am J Hematol,1994,47(4):278-282.
  • 7Jegalian AG,Facchetti F,Jaffe ES.Plasmacytoid dendritic cells:physiologic roles and pathologic states[J].Adv Anat Pathol,2009,16(6):392-404.
  • 8Petrella T,Meijer CJ,Dalac S,et al.TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphoma) and leukemia cutis[J].Am J Clin Pathol,2004,122(2):307-313.
  • 9Marafioti T,Paterson JC,Ballabio E,et al.Novel markers of normal and neoplastic human plasmacytoid dendritic cells[J].Blood,2008,111(7):3778-3792.
  • 10Dzionek A,Inagaki Y,Okawa K,et al.Plasmacytoid dendritic cells:from specific surface markers to specific celluar functions[J].Hum Immunol,2002,63(12):1133-1148.

共引文献5

同被引文献90

  • 1于明华,蔡文宇,田欣,李梅,郑迎春,陈晟华.母细胞性浆细胞样树突细胞肿瘤1例[J].临床检验杂志(电子版),2013,2(1):312-313. 被引量:1
  • 2许可见,李汉忠,师杰,晋红中,刘跃华.滤泡树突状细胞肉瘤相关的副肿瘤天疱疮[J].临床皮肤科杂志,2006,35(12):794-796. 被引量:7
  • 3Monda L, Wamker R, Rosai J. Aprinary lymph node malignancy with features suggestive of dendritic reticulum cell differentiation [J]. Am J Pathol, 1986,122(3) :562 -72.
  • 4Swerdlow S H, Campo E, Harris N L, et al. WHO classification of tumours of haematopoietic and lymphoid tissues [ M ]. Lyon: IARC Press, 2008:363 -4.
  • 5Duan G J, Wu F, Zhu J, et al. Extranodal follicular dendritic cell sarcoma of the pharyngeal region: a potential diagnostic pitfall, with literature review[J]. Am J Clin Pathol, 2010.1 (33) :49 -58.
  • 6Wang J, Bu D F, Li T, et al. Autoantibody Production from a thy- mana and a follicular dendritic cell sarcoma associated with parane-oplastic pemphigus [ J ]. Br J Dermatol, 2005,152 ( 3 ) :558 - 64.
  • 7Zhang Z X, Cheng J, Shi Q L, et al. Follicular dendritic cell sar- coma a clinicop athologic study of 8 cases [ J ]. Chin J Pathol, 2008,37(6) :395 -9.
  • 8Vermi W, Lonardi S, Bosisio D, et al. Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma [ J ]. Am J Pathol, 2008,31 (3) :356 -64.
  • 9Zhang H, Maitta R W, Bhattacharyya P K. 3,-Synuclein is a prom- ising new marker for staining reactive follicular dendritic cells, follicular dendritic cell sarcoma, Kaposi sarcoma, and benign and malignant vascular tumors[J]. Am J Surg Pathol, 2011,35(12) : 1857 - 65.
  • 10Bai L Y, Kwang W K, Chiang I P, et al. Follicular dendritic cell tumor of the liver associated with Epstein-barr virus[ J]. Jpa J Clin Oncol, 2006,36(4) :249 -53.

引证文献9

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部